Letswai la disodium la ATP CAS 987-65-5

CAS:987-65-5

Bohloeki:99%

Foromo ea limolek'hule:C10H17N5NaO13P3

Boima ba limolek'hule:531.18

EINECS:213-579-1

Nako ea Polokelo:lilemo tse 2

Mantsoe a tšoanang:ADENOSINETRIPHOSPHATEDIUM; ADENOSINETRIPHOSPHATE,DISODIUMLETSA; ADENYLPYROPHOSPHORICACIDDISODIUMLETSA; ADENOSINE-5′-TRIPHOSPHATEHYDRATEDISODIUMLETSA; ADENOSINE-5′-TRIPHOSPHATEHYDRATEDISODIUMLETSA; ADENOSINE-5′-TRIPHOSPHATENA2-LETSOAI; ADENOSINE-5′-TRIPHOSPHATENA2-LETSOAI; ADENOSINE-5′-TRIPHOSPHORICACIDDISODIUMLETSA; ADENOSINE5′-TRIPHOSPHORICACIDDISODIUMLETSA; ADENOSINE5′-TRIPHOSPHORICACIDDISODIUMLETSA

Siea Molaetsa oa Hao

Qaqiso ea Sehlahisoa

Khoasolla

Li-tag tsa Sehlahisoa

Letswai la ATP disodium CAS 987-65-5 ke eng?

Letswai la disodium la ATP ke metabolite ea adenosine, nucleoside triphosphate e sebetsang ka bongata e sebelisoang e le coenzyme bakeng sa phetisetso ea matla ka har'a sele liseleng. E tsamaisa matla a lik'hemik'hale ka har'a lisele bakeng sa metabolism. Letsoai la disodium la ATP le sebelisoa ho kopanya li-analog tsa deoxyadenosine diphosphate tse fetotsoeng ke ribose e le li-receptor ligands tsa P2Y1.

Tlhaloso

Ponahalo	Phofo e tšoeu kapa phofo e tšoeu kapa phofo ea kristale, e nang le hygroscopic.
Boholo ba likaroloana	＞95% e feta ka har'a letlooeng la 80.
pH	2.5～3.5
Ho qhibiliha ha metsi	E qhibiliha ka metsing; ha e qhibilihe ka har'a ethanol le ether.
Odara	Oderless
Metsi a mangata	6.0%~12.0%
Chloride	≤0.05%
Letswai la tšepe	≤0.001%
Litšepe tse boima	≤0.001%
Moetapele	≤2.0ppm
Arsenic	≤1.0ppm

Kopo

1. Tšebeliso ea lipatlisiso tsa indasteri le tsa saense
(1) Lisebelisoa tse tala tsa botle: li eketsoa lihlahisoa tsa tlhokomelo ea letlalo tse thibelang botsofali, li ka ntlafatsa ho tenyetseha ha letlalo le ho benya ka ho kenya tšebetsong metabolism ea matla a sele.
(2) Dijo tse eketsang: di sebediswa e le se eketsang phepo dinong tsa dipapadi le dijong tse sebetsang ho tlatsa matla kapele.
2. Libaka tsa kalafo ea bongaka
(1) Mafu a tsamaiso ea pelo le methapo ea mali: a sebelisetsoa ho hloleha ha pelo, myocarditis, infarction ea myocardial le arteriosclerosis ea boko, jj., ka ho ntlafatsa metabolism ea matla a pelo le ho atolosa methapo ea pelo (ho eketsa phallo ea mali ka hoo e ka bang 30%), ho imolla matšoao a ischemia ea myocardial. Mohlala, ho bakuli ba nang le infarction e matla ea myocardial, ATP disodium e ka khutsufatsa nako ea ho oa ha ST segment le ho fokotsa boleng bo holimo ba spectrum ea enzyme ea myocardial.
(2) Mafu a tsamaiso ea methapo: kalafo e thusang ea liphello tsa ho tsoa mali bokong, tšenyo ea boko le ho putlama ha mesifa ho tsoelang pele, ka ho kenella mokoallong oa mali le bokong (ho kenella ha mali ho ka ba 65%), ho khothaletsa ho lokisoa ha lera la lisele tsa methapo le tsosoloso ea ts'ebetso ea methapo, le ho ntlafatsa lebelo la ho tsamaisa methapo.
(3) Mafu a metabolism: Kalafong ea lefu la sebete le cirrhosis, ATP disodium e ka ntlafatsa ts'ebetso ea mitochondrial ea li-hepatocyte, ea potlakisa tokiso ea li-hepatocyte, le ho fokotsa maemo a ALT le AST; e boetse e na le phello e thusang ea ntlafatso mathateng a lefu la tsoekere (joalo ka neuropathy ea peripheral).
3. Libaka tse hlahellang tsa ts'ebeliso
(1) Sistimi ea ho fana ka meriana e reretsoeng: ATP disodium e ka sebelisoa e le sesebelisoa sa ho fetola, se kopantsoeng le liposomes kapa nanoparticles, ho fihlella ho fana ka meriana e reretsoeng ka endocytosis e tsamaisoang ke receptor. Mohlala, kalafong ea hlahala, nanomedicines e fetotsoeng ke ATP e ka ntlafatsa bokhoni ba ho bolaea ba meriana ea chemotherapy liseleng tsa mofetše.
(2) Temo ea sele le meriana ea biopharmaceuticals: E le karolo ea bohlokoa ea mokhoa oa ho lema lisele, ATP disodium e ka khothaletsa kholo le tlhahiso ea protheine ea lisele tsa CHO, lisele tsa HEK293, jj., 'me e sebelisoa haholo tlhahisong ea li-antibody tsa monoclonal.